Universal pharmacare benefits business and working families
By Anita Huberman & Hassan YussuffFeb. 25, 2019
The federal government can be on the right side of history as the upcoming election looms. Or, it can offer costly half measures that mostly benefit big pharma and the insurance industries and leave the rest of us out in the cold. The choice is clear.
This is the unfinished business of medicare, as contemplated by Tommy Douglas, right, pictured with Thérèse Casgrain in 1995, the visionary of our cherished health-care system, write Anita Huberman and Hassan Yussuff. Photograph courtesy of Wikimedia Commons
Every government struggles with how best to support the people it serves. One hopes and assumes that decisions are based on thorough research, meaningful consultations, and with the guidance of experts in the field.
People. Policy. Politics. This is an exclusive subscriber-only story.
Changes to address Indigenous language loss and child welfare are seen as ‘high priority,’ but with calls for broad amendments, the short timeframe left to pass bills C-91 and C-92 is a source of frustration for some.
Amid allegations of partisanship against Michael Wernick, Prof. Donald Savoie says he could stay as DM to the PM and secretary to cabinet, but another bureaucrat may be better suited as the public service head.
The Globe and Mail bureau chief's vast source list and eye for detail has helped him expose numerous government scandals, including the SNC-Lavalin affair, which he broke with Steven Chase and Sean Fine.
While Justin Trudeau's poll numbers have sunk amid the controversy, Andrew Scheer and Jagmeet Singh have not seen a boost to their own polling numbers as opposition leaders. But it's still early days, say strategists.